ID   SCRC-1
AC   CVCL_W962
SY   Small Cell Renal Carcinoma-1
DR   Wikidata; Q54952489
RX   PubMed=10688041;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 91.4 hours (PubMed=10688041).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C116317; Kidney small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
RX   PubMed=10688041; DOI=10.1016/S0022-5347(05)67874-3;
RA   Chuang C.-K., Shen Y.-C., Wu J.-H., Tsai L.-H., Liao S.-K.;
RT   "Immunobiologic, cytogenetic and drug response features of a newly
RT   established cell line (SCRC-1) from renal small cell carcinoma.";
RL   J. Urol. 163:1016-1021(2000).
//